Aiforia’s mission is to provide global access to AI-powered image analysis for medical, healthcare professionals and beyond.
Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology and experienced life science entrepreneurs. The Aiforia® Platform brings together deep learning AI and high-performance cloud computing. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries and clinical support with highly accurate and consistent data. Aiforia is technologically driven establishment and keeps the capability of being image agnostic thus extending its solutions to multiple fields.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 8, 2021 | Series B | €12.60M | 1 | PHC Holdings | — | Detail |
Sep 20, 2019 | Grant | €2.05M | 1 | European Innovation Council | — | Detail |
Dec 1, 2017 | Series A | €5M | 3 | Ascend Capital Partners | — | Detail |
Oct 19, 2015 | Seed | €1.50M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
PHC Holdings | Yes | Series B |
European Innovation Council | Yes | Grant |
Ascend Capital Partners | Yes | Series A |
ACME Investments | — | Series A |
Sto-Rahoitus | — | Series A |
Business Finland | — | Seed |
Jukka Tapaninen | — | Seed |
Marten Mickos | — | Seed |